Responses
Clinical/translational cancer immunotherapy
Original research
Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.